Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (vol, pg, 2019)

被引：4
|
作者：
Xu, Jiangsheng
Liu, Yunhua
Li, Yujing
Wang, Hai
Stewart, Samantha
Van der Jeught, Kevin
Agarwal, Pranay
Zhang, Yuntian
Liu, Sheng
Zhao, Gang
Wan, Jun
Lu, Xiongbin
He, Xiaoming
机构：
[1] University of Maryland,Fischell Department of Bioengineering
[2] The Ohio State University,Comprehensive Cancer Centre
[3] The Ohio State University,Department of Biomedical Engineering
[4] Indiana University School of Medicine,Department of Medical and Molecular Genetics
[5] Indiana University School of Medicine,Melvin and Bren Simon Cancer Centre
[6] University of Science and Technology of China,Department of Electronics Science and Technology
[7] University of Maryland,Robert E. Fischell Institute for Biomedical Devices
[8] University of Maryland,Marlene and Stewart Greenebaum Comprehensive Cancer Centre
来源：
NATURE NANOTECHNOLOGY | 2020年 / 15卷 / 04期
关键词：
D O I：
10.1038/s41565-020-0635-3
中图分类号：
TB3 [工程材料学];
学科分类号：
0805 ; 080502 ;
摘要：
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [1] Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (vol 14, pg 388, 2019)
    Xu, Jiangsheng
    Liu, Yunhua
    Li, Yujing
    Wang, Hai
    Stewart, Samantha
    Van der Jeught, Kevin
    Agarwal, Pranay
    Zhang, Yuntian
    Liu, Sheng
    Zhao, Gang
    Wan, Jun
    Lu, Xiongbin
    He, Xiaoming
    NATURE NANOTECHNOLOGY, 2019, 14 (05) : 496 - 496
  • [2] Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
    Xu, Jiangsheng
    Liu, Yunhua
    Li, Yujing
    Wang, Hai
    Stewart, Samantha
    Van der Jeught, Kevin
    Agarwal, Pranay
    Zhang, Yuntian
    Liu, Sheng
    Zhao, Gang
    Wan, Jun
    Lu, Xiongbin
    He, Xiaoming
    NATURE NANOTECHNOLOGY, 2019, 14 (04) : 388 - +
  • [3] Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
    Jiangsheng Xu
    Yunhua Liu
    Yujing Li
    Hai Wang
    Samantha Stewart
    Kevin Van der Jeught
    Pranay Agarwal
    Yuntian Zhang
    Sheng Liu
    Gang Zhao
    Jun Wan
    Xiongbin Lu
    Xiaoming He
    Nature Nanotechnology, 2019, 14 : 388 - 397
  • [4] Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
    Jiangsheng Xu
    Yunhua Liu
    Yujing Li
    Hai Wang
    Samantha Stewart
    Kevin Van der Jeught
    Pranay Agarwal
    Yuntian Zhang
    Sheng Liu
    Gang Zhao
    Jun Wan
    Xiongbin Lu
    Xiaoming He
    Nature Nanotechnology, 2019, 14 : 496 - 496
  • [5] Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
    Jiangsheng Xu
    Yunhua Liu
    Yujing Li
    Hai Wang
    Samantha Stewart
    Kevin Van der Jeught
    Pranay Agarwal
    Yuntian Zhang
    Sheng Liu
    Gang Zhao
    Jun Wan
    Xiongbin Lu
    Xiaoming He
    Nature Nanotechnology, 2020, 15 : 342 - 342
  • [6] Precise targeting of POLR2A for treating triple negative breast cancer with Chr17p loss
    Lu, Xiongbin
    Li, Yujing
    Sun, Yifan
    Van der Jeught, Kevin
    Kulke, Michael
    Andreas, Pahl
    Zhang, Xinna
    He, Xiaoming
    Zhang, Chi
    CANCER RESEARCH, 2020, 80 (04)
  • [7] Targeting tankyrases as a therapeutic strategy for triple-negative breast cancer
    Mathew, Maya
    Campo, Loredana
    Kim, Jung-Lye
    Ha, Geun-Hyoung
    Breuer, Eun-Kyoung
    CANCER RESEARCH, 2017, 77
  • [8] Therapeutic targeting of ERβ in triple negative breast cancer
    Reese, Jordan M.
    Subramaniam, Malayannan
    Suman, Vera J.
    Wu, Xianglin
    Negron, Vivian
    Gingery, Anne
    Pitel, Kevin S.
    Shah, Sejal S.
    Cunliffe, Heather E.
    McCullough, Ann E.
    Pockaj, Barbara A.
    Spelsberg, Thomas C.
    Goetz, Matthew P.
    Ingle, James N.
    Hawse, John R.
    CANCER RESEARCH, 2015, 75
  • [9] The strategy of precise targeting and in situ oxygenating for enhanced triple-negative breast cancer chemophototherapy
    Wu, Manxiang
    Chen, Tianxiang
    Wang, Lianfu
    Akakuru, Ozioma Udochukwu
    Ma, Xuehua
    Xu, Jinshan
    Hu, Jiapeng
    Chen, Jia
    Fang, Qianlan
    Wu, Aiguo
    Li, Qiang
    NANOSCALE, 2022, 14 (23) : 8349 - 8361
  • [10] Novel Therapeutic Strategy for Triple Negative Breast Cancer Targeting hERO1-Lα
    Wada, Asaka
    Hirohashi, Yoshihiko
    Kutomi, Goro
    Shima, Hiroaki
    Murata, Kenji
    Kubo, Terufumi
    Tsukahara, Tomohide
    Tamura, Yasuaki
    Torigoe, Toshihiko
    Takemasa, Ichiro
    CANCER SCIENCE, 2023, 114 : 1486 - 1486
12345